Likewise, Michaux et al. (2019) reported a range of blood measures as outcomes related to this programme, including serum ferritin, serum zinc, soluble transferrin receptor (sTfR), retinol binding protein, C‐reactive protein, α‐1 acid glycoprotein (AGP), and Hb concentrations, as well as anaemia rates for nonpregnant women. The gene discussed is ATP5MK; the disease is anemia.